June 16, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
CHICAGO — Tirzepatide may impact how the body burns energy by activating brown adipose tissue, according to results of a small study presented at ENDO 2026.“Over the past 2 decades we have learned that brown adipose tissue is present and functional in adult humans and that its activity is closely linked to cardiometabolic health. In obesity, brown fat activity is markedly reduced,
June 16, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

CHICAGO — In patients with obesity, exercise as assessed by wearable-measured activity declined after they initiated GLP-1…

Adults with obesity receiving tirzepatide 10 mg or 15 mg may be able to maintain most of their weight loss after switching to a…

DENVER — Adults with active psoriatic arthritis and obesity had improvements in disease activity, physical function, weight loss…

A once-weekly triple receptor agonist conferred up to 28.3% weight loss at 80 weeks for adults with overweight or obesity,…

Adults with moderate to severe psoriasis and overweight or obesity were more likely to achieve complete skin clearance plus…

NEW ORLEANS — Weekly petrelintide demonstrated clinically meaningful weight loss through 42 weeks and was well tolerated among…